TNGX

Healthcare

Tango Therapeutics, Inc.

$17.19+0.04 (+0.23%)

Prev Close

$17.15

Open

$17.25

High

$17.58

Low

$16.77

Volume

3.00M

Market Cap

$1.82B

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Tango Therapeutics, Inc. (TNGX) has been exclusively selling, with 0 insider purchases totaling $0.00 and 8 insider sales totaling $2.45M. The most recent insider transaction was by Crystal Adam (officer: President, R&D), who sold $303.8K worth of shares on Mar 9, 2026. Tango Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.82B.

Buys (12M)

$0.00

Sells (12M)

$2.45M

Net Activity

Net Seller

$2.45M

Active Insiders

last 12 mo

TNGX Price Chart

TNGX Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 9, 2026↗	Crystal Adam	officer: President, R&D	Sell	20,251	$15.00	$303.8K	112,622
Feb 27, 2026↗	Crystal Adam	officer: President, R&D	Sell	54,345	$12.77	$694.2K	132,873
Feb 4, 2026↗	Beckman Daniella	officer: Chief Financial Officer	Sell	10,317	$12.26	$126.5K	184,410
Feb 4, 2026↗	Crystal Adam	officer: President, R&D	Sell	18,452	$12.26	$226.3K	187,419
Feb 4, 2026↗	Weber Barbara	director, officer: Director, Executive Chair	Sell	30,519	$12.26	$374.3K	1,629,590
Feb 2, 2026↗	Beckman Daniella	Chief Financial Officer	Sell	10,317	$12.26	$126.5K	0
Feb 2, 2026↗	Crystal Adam	President, R&D	Sell	18,452	$12.26	$226.3K	0
Feb 2, 2026↗	Weber Barbara	Director, Executive Chair	Sell	30,519	$12.26	$374.3K	0

TNGX Insider Buying Activity

The following table shows recent insider purchases of Tango Therapeutics, Inc. (TNGX) stock reported via SEC Form 4 filings.

No insider buying activity found for TNGX in the last 12 months.

TNGX Insider Selling Activity

The following table shows recent insider sales of Tango Therapeutics, Inc. (TNGX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 9, 2026↗	Crystal Adam	officer: President, R&D	Sell	20,251	$15.00	$303.8K	112,622
Feb 27, 2026↗	Crystal Adam	officer: President, R&D	Sell	54,345	$12.77	$694.2K	132,873
Feb 4, 2026↗	Beckman Daniella	officer: Chief Financial Officer	Sell	10,317	$12.26	$126.5K	184,410
Feb 4, 2026↗	Crystal Adam	officer: President, R&D	Sell	18,452	$12.26	$226.3K	187,419
Feb 4, 2026↗	Weber Barbara	director, officer: Director, Executive Chair	Sell	30,519	$12.26	$374.3K	1,629,590
Feb 2, 2026↗	Beckman Daniella	Chief Financial Officer	Sell	10,317	$12.26	$126.5K	0
Feb 2, 2026↗	Crystal Adam	President, R&D	Sell	18,452	$12.26	$226.3K	0
Feb 2, 2026↗	Weber Barbara	Director, Executive Chair	Sell	30,519	$12.26	$374.3K	0